This inventor holds 2 USPTO granted patents. Top assignee: Glaxo Wellcome Inc.. Active years: 1999-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- London, GB (1999)
- Stevenage, GB (2000)
Company Filing History:
Years Active: 1999-2000
Title: The Innovations of Andrew Michael Pennell
Introduction
Andrew Michael Pennell is a notable inventor based in Stevenage, GB. He has made significant contributions to the field of pharmaceuticals, particularly through his work on various chemical compounds. With a total of 2 patents to his name, Pennell has demonstrated a commitment to advancing medical science.
Latest Patents
Among his latest patents are "Piperidine derivatives having tachykinin antagonist activity" and "Adenosine derivatives." These innovations reflect his focus on developing new therapeutic agents that could potentially improve patient outcomes.
Career Highlights
Pennell is currently employed at Glaxo Wellcome Inc., a leading pharmaceutical company known for its research and development in healthcare. His work at this organization has allowed him to explore and innovate in the realm of medicinal chemistry.
Collaborations
Throughout his career, Pennell has collaborated with esteemed colleagues such as Duncan Robert Armour and Gerard Martin Giblin. These partnerships have likely contributed to the success of his research and patent applications.
Conclusion
Andrew Michael Pennell's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile